FrancophonIA/ELRC3.0 huggingface dataset:
English: Oral uptake of the product at the maximum recommended dose was well tolerated in cats, apart from some self-limiting salivation and coughing or vomiting immediately after administration.
Danish: Oral optagelse af produktet ved den højeste anbefalede dosis tolereredes godt hos katte bortset fra nogle selvbegrænsende tilfælde af savlen og hoste eller opkastning umiddelbart efter påføring.
English: Step 2: The dog should be standing or lying with its back horizontal during application.
Danish: Trin 2: Hunden skal stå eller ligge med ryggen i vandret stilling under påføringen.
English: Oral uptake of the product at the maximum recommended dose of 93 mg fluralaner/kg body weight was well tolerated in cats, apart from some self-limiting salivation and coughing or vomiting immediately after administration.
Danish: Oral optagelse af produktet ved den højeste anbefalede dosis på 93 mg fluralaner/kg kropsvægt tolereredes godt hos katte bortset fra nogle selvbegrænsende tilfælde af savlen og hoste eller opkastning umiddelbart efter påføring.
English: Keep the product in the original packaging until use, in order to prevent children from getting direct access to the product.
Danish: Opbevar produktet i den originale emballage indtil brug for at undgå, at børn får direkte adgang til produktet.
English: 1 chewable tablet 2 chewable tablets 4 chewable tablets
Danish: 1 tyggetablet 2 tyggetabletter 4 tyggetabletter
English: Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.
Danish: Lopper og flåter skal bide sig fast på værten og starte indtag af føde, før de udsættes for det aktive stof.
English: Keep the product in the original packaging until use in order to prevent children from getting access to the product.
Danish: Opbevar produktet i den originale emballage indtil brug for at undgå, at børn får adgang til produktet.
English: Fluralaner is highly bound to plasma proteins and might compete with other highly bound active substances such as non-steroidal anti-inflammatory drugs (NSAIDs) and the coumarin derivative warfarin.
Danish: Fluralaner har en høj bindingsgrad til plasmaproteiner og kan muligvis konkurrere med andre stærkt bundne aktive stoffer såsom non-steroide anti-inflammatoriske (NSAID) præparater og kumarinderivatet warfarin.
English: Convulsions and lethargy has been reported very rarely in spontaneous reports.
Danish: Kramper og letargi er rapporteret i meget sjældne tilfælde i spontane indberetninger.
English: In in vitro bio-assays, fluralaner is not affected by proven field resistances against amidines (tick), organophosphates (tick, mite), cyclodienes (tick, flea, fly), macrocyclic lactones (sea lice), phenylpyrazoles (tick, flea), benzophenyl ureas (tick), pyrethroids (tick, mite) and carbamates (mite).
Danish: I in vitro-bioassays påvirkes fluralaner ikke af påvist resistens over for amidiner (flåt), organophosphater (flåt, mide), cyclodiener (flåt, loppe, flue), makrocykliske laktoner (havlus), phenylpyrazoler (flåt, loppe ), benzophenyl urinstoffer (flåt), pyrethroider (flåt, mide) og carbamater (mide).
English: EXP: (MM/YYYY)
Danish: EXP: {MM/ÅÅÅÅ}
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Danish: Hyppigheden af bivirkninger er defineret som: - meget almindelige (flere end 1 ud af 10 behandlede dyr, der viser bivirkninger i løbet af en behandling) - almindelige (flere end 1, men færre end 10 dyr ud af 100 behandlede dyr) - ikke almindelige (flere end 1, men færre end 10 dyr ud af 1.000 behandlede dyr) - sjældne (flere end 1, men færre end 10 dyr ud af 10.000 behandlede dyr) - meget sjældne (færre end 1 dyr ud af 10.000 behandlede dyr, herunder isolerede rapporter).
English: Each chewable tablet of Bravecto contains:
Danish: Hver Bravecto tyggetablet indeholder:
English: on the cat.
Danish: på katte.
English: Treatment schedule:
Danish: Behandlingsskema:
English: The following other signs shortly after administration were uncommonly observed: apathy/tremors/anorexia (0.9% of treated cats) or vomiting/hypersalivation (0.4% of treated cats).
Danish: Følgende andre ikke almindelige symptomer er observeret kort efter påføring: apati, tremor og anoreksi (0,9 % af behandlede katte) eller opkastning og hypersalivation (0,4 % af behandlede katte).
English: It is efficacious against ticks (Ixodes spp.)
Danish: Det er effektivt mod flåter (Ixodes spp.)
English: Bodyweight of cat (kg)
Danish: Kattens vægt (kg)
English: Pregnancy, lactation and fertility: The veterinary medicinal product can be used in breeding, pregnant and lactating dogs.
Danish: Drægtighed, laktation og fertilitet: Dette veterinærlægemiddel kan anvendes til avlshunde samt drægtige og diegivende hunde.
English: Some marbling, speckles or both may be visible.
Danish: Der kan forekomme synlig marmorering og/eller prikker.
English: The product should be applied on cats up to 6.25 kg body weight in one spot at the base of the skull and in two spots on cats greater than 6.25 kg bodyweight.
Danish: Produktet anvendes ved at påføre indholdet i nakken, helt oppe hvor man kan mærke, kraniet slutter: for katte med en kropsvægt på op til 6,25 kg påføres indholdet på ét enkelt sted og for katte med en kropsvægt på over 6,25 kg på to steder.
English: The product should not be administered at intervals shorter than 8 weeks as the safety at shorter intervals has not been tested.
Danish: Produktet bør ikke administreres hyppigere end med 8 ugers interval, da sikkerheden ved kortere intervaller ikke er blevet testet.
English: The pipette should be held by the base or by the upper rigid portion below the cap in an upright position (tip up) for opening it.
Danish: Hold om pipetten i bunden, der hvor den er sammensvejst, eller omkring den hårde del lige under hætten i oprejst stilling (spidsen skal vende opad), når den åbnes.
English: on the dog.
Danish: på hunde.
English: Administer Bravecto chewable tablets at or around the time of feeding.
Danish: Indgiv Bravecto tyggetabletter på fodringstidspunktet eller umiddelbart før eller efter.
English: Safety was demonstrated in breeding, pregnant and lactating animals treated with overdoses of up to 3 times the maximum recommended dose.
Danish: Sikkerhed er påvist hos avlshunde samt drægtige og diegivende hunde, som blev behandlet med en overdosis på op til 3 gange den anbefalede højeste dosis.
English: Cap does not come off.
Danish: Hætten kan ikke tages af.
English: There were no findings on reproductive performance and no findings of concern on offspring viability when fluralaner was administered orally to Beagle dogs at overdoses of up to 3 times the maximum recommended dose (up to 168 mg/kg bodyweight of fluralaner).
Danish: Der sås ingen indvirkning på reproduktionsevnen og ingen indvirkning af betydning på hvalpes levedygtighed, når fluralaner blev administreret oralt til Beagle-hunde ved en overdosis op til 3 gange den maksimalt anbefalede dosis (op til 168 mg/kg kropsvægt fluralaner).
English: For the treatment of tick and flea infestations in cats.
Danish: Til behandling af flåt- og loppeangreb hos katte.
English: The prolonged persistence and slow elimination from plasma (t1/2 = 21 days) and the lack of extensive metabolism provide effective concentrations of fluralaner for the duration of the inter-dosing interval.
Danish: Den øgede biotilgængelighed og langsomme udskillelse fra plasma (t1/2 = 21 dage) samt den ringe metabolisme giver effektive koncentrationer af fluralaner inden for hele doseringsintervallet.
English: The prolonged persistence and slow elimination from plasma (t1/2 = 12 days) and the lack of extensive metabolism provide effective concentrations of fluralaner for the duration of the inter-dosing interval.
Danish: Den øgede biotilgængelighed og langsomme udskillelse fra plasma (t1/2 = 12 dage) samt den ringe metabolisme giver effektive koncentrationer af fluralaner inden for hele doseringsintervallet.
English: Newly emerged fleas on a dog are killed before viable eggs are produced.
Danish: Nye loppeangreb på hunden bekæmpes, før loppen kan nå at producere levedygtige æg.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Sachet
Danish: MINDSTEKRAV TIL OPLYSNINGER PÅ SMÅ INDRE PAKNINGER Brev
English: Incompatibilities: None known.
Danish: Uforligeligheder Ingen kendte.
English: Bravecto chewable tablets
Danish: Bravecto tyggetabletter
English: Intervet International B. V. Wim de Körverstraat 35 5831 AN Boxmeer The NETHERLANDS
Danish: Wim de Körverstraat 35 5831 AN Boxmeer Holland
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Cardboard box
Danish: OPLYSNINGER, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE ÆSKE
English: Soya-bean oil
Danish: Sojaolie
English: Spot-on solution:
Danish: Spot-on, opløsning:
English: The onset of efficacy is within 12 hours for fleas (C. felis) and within 48 hours for ticks (I. ricinus).
Danish: Virkningen indtræder inden for 12 timer for lopper (C. felis) og 48 timer for flåter (I. ricinus).
English: The onset of efficacy is within 8 hours for fleas (C. felis) and 12 hours for ticks (I. ricinus).
Danish: Virkningen indtræder inden for 8 timer for lopper (C. felis) og 12 timer for flåter (I. ricinus).
English: Shelf life of the veterinary medicinal product as packaged for sale: Bravecto 112.5 mg spot-on solution: 2 years Bravecto 250 mg / 500 mg spot-on solution: 3 years
Danish: Opbevaringstid for veterinærlægemidlet i salgspakning: Bravecto 112,5 mg spot-on, opløsning: 2 år Bravecto 250 mg / 500 mg spot-on, opløsning: 3 år
English: for small cats 1.2 - 2.8 kg for medium-sized cats >2.8 - 6.25 kg for large cats >6.25 - 12.5 kg
Danish: til små katte (1,2 - 2,8 kg) til mellemstore katte (> 2,8 - 6,25 kg) til store katte (> 6,25 - 12,5 kg)
English: During clinical field testing, no interactions between Bravecto chewable tablets for dogs and routinely used veterinary medicinal products were observed.
Danish: Ved kliniske pilotstudier blev der ikke fundet nogen interaktion mellem Bravecto tyggetabletter til hunde og hyppigt anvendte veterinære lægemidler.
English: Convulsions and lethargy has been reported very rarely in spontaneous (pharmacovigilance) reports.
Danish: Kramper og letargi (søvnlignende sløvhedstilstand) er rapporteret i meget sjældne tilfælde i spontane bivirkningsindberetninger.
English: For the treatment of tick and flea infestations in dogs.
Danish: Til behandling af flåt- og loppeangreb hos hunde.
English: For optimal control of tick and flea infestation, the product should be administered at intervals of 12 weeks.
Danish: Behandlingsskema For at opnå optimal kontrol af flåt- og loppeangreb skal lægemidlet gives med 12 ugers mellemrum.
English: The product should not be used by persons with a hypersensitivity to the active substance or to any of the excipients (see section Contraindications).
Danish: Produktet må ikke anvendes af personer med overfølsomhed over for det aktive stof eller over for et eller flere af hjælpestofferne (se afsnittet ”Kontraindikationer”).
English: Chewable tablets:
Danish: Tyggetabletter:
English: In the absence of available data, this veterinary medicinal product should not be used on kitten less than 11 weeks old and /or cats weighing less than 1.2 kg.
Danish: På grund af manglende data bør dette veterinærlægemiddel ikke anvendes til killinger under 11 uger og/eller katte, der vejer mindre end 1,2 kg.
English: The product contributes towards the control of environmental flea populations in areas to which treated dogs have access.
Danish: Produktet bidrager til kontrol af forekomsten af lopper i de områder, som behandlede hunde har adgang til.
English: Can be used in breeding, pregnant and lactating dogs.
Danish: Kan anvendes til avlshunde, drægtige hunde og diegivende hunde.
English: For cats above 12.5 kg body weight, use a combination of two pipettes that most closely matches the body weight.
Danish: Til katte, der vejer mere end 12,5 kg, anvendes to pipetter, hvis styrke tilsammen passer bedst til kropsvægten.
English: Pregnancy, lactation and fertility: Can be used in breeding, pregnant and lactating dogs.
Danish: Drægtighed, diegivning og fertilitet Kan anvendes til avlshunde, drægtige hunde og diegivende hunde.
English: For dogs above 56 kg bodyweight, use a combination of two tablets that most closely matches the bodyweight.
Danish: Til hunde, der vejer mere end 56 kg, anvendes to tabletter, som tilsammen passer bedst til kropsvægten.
English: Mild and transient gastrointestinal effects such as diarrhoea, vomiting, inappetence, and drooling were commonly observed in clinical trials (1.6% of treated dogs).
Danish: Milde og forbigående gastrointestinale forstyrrelser såsom diarré, opkastning, appetitløshed og savlen var almindeligt observerede bivirkninger i kliniske studier (1,6 % af de behandlede hunde).
English: During laboratory and clinical field testing, no interactions between Bravecto spot-on solution for cats and routinely used veterinary medicinal products were observed.
Danish: Ved laboratorieundersøgelser og kliniske feltstudier blev der ikke fundet nogen interaktion mellem Bravecto spot-on, opløsning, til katte og hyppigt anvendte veterinærlægemidler.
English: The product should not be used by persons with a hypersensitivity to the active substance or to any of the excipients (see contraindications, section 4.3).
Danish: Produktet må ikke anvendes af personer med overfølsomhed over for det aktive stof eller over for et eller flere af hjælpestofferne (se kontraindikationer, pkt.
English: Bravecto 112.5 mg (2-4.5 kg) Bravecto 250 mg (>4.5 -10 kg) Bravecto 500 mg (>10 -20 kg) Bravecto 1,000 mg (>20 -40 kg) Bravecto 1,400 mg (>40 -56 kg) fluralaner
Danish: Bravecto 112,5 mg (2-4,5 kg) Bravecto 250 mg (>4,5-10 kg) Bravecto 500 mg (>10-20 kg) Bravecto 1.000 mg (>20-40 kg) Bravecto 1.400 mg (>40-56 kg)
English: Fluralaner was well tolerated in Collies with a deficient multidrug-resistance-protein 1 (MDR1 -/-) following single oral administration at 3 times the maximum recommended dose (168 mg/kg bodyweight).
Danish: Fluralaner tolereredes godt hos Collier, der er bærere af MDR1 gendefekt (Multidrug Resistance) efter en enkelt oral administration 3 gange den anbefalede højeste dosis (168 mg/kg kropsvægt).
English: During laboratory and clinical field testing, no interactions between Bravecto spot-on solution for dogs and routinely used veterinary medicinal products were observed.
Danish: Ved laboratorieundersøgelser og kliniske feltstudier blev der ikke fundet nogen interaktion mellem Bravecto spot-on, opløsning, til hunde og hyppigt anvendte veterinærlægemidler.
English: For optimal control of tick infestation, the timing of retreatment depends on the tick species.
Danish: Behandlingsinterval for at opnå optimal kontrol af flåtangreb afhænger af flåtarten.
English: EU/2/13/158/001 EU/2/13/158/002 EU/2/13/158/003 EU/2/13/158/004 EU/2/13/158/005 EU/2/13/158/006 EU/2/13/158/007 EU/2/13/158/008 EU/2/13/158/009 EU/2/13/158/010 EU/2/13/158/011 EU/2/13/158/012 EU/2/13/158/013
Danish: EU/2/13/158/001 EU/2/13/158/002 EU/2/13/158/003 EU/2/13/158/004 EU/2/13/158/005 EU/2/13/158/006 EU/2/13/158/007 EU/2/13/158/008 EU/2/13/158/009
English: For dogs above 56 kg body weight, use a combination of two pipettes that most closely matches the body weight.
Danish: Til hunde, der vejer mere end 56 kg, anvendes to pipetter, hvis styrke tilsammen passer bedst til kropsvægten.
English: Bravecto should be administered in accordance with the following table (corresponding to a dose of 40 - 94 mg fluralaner/kg body weight):
Danish: Bravecto gives i henhold til nedenstående tabel (svarende til en dosis på 40 - 94 mg fluralaner/kg kropsvægt):
English: Overdose:
Danish: INDLÆGSSEDDEL:
English: No adverse reactions were observed following topical administration to kitten aged 11-13 weeks and weighing 1.2-1.5 kg treated with overdoses of up to 5 times the maximum recommended dose (93 mg, 279 mg and 465 mg fluralaner/kg body weight) on three occasions at shorter intervals than recommended (8-week intervals).
Danish: Der blev hos killinger i alderen 11-13 uger og med en vægt på 1,2-1,5 kg ikke observeret bivirkninger efter topikal administration af op til 5 gange den højeste anbefalede dosis (93 mg, 279 mg og 465 mg fluralaner/kg kropsvægt) ved tre lejligheder med kortere interval end anbefalet (8 ugers interval).
English: The safety of the veterinary medicinal product in breeding, pregnant and lactating dogs has been demonstrated.
Danish: Veterinærlægemidlet er blevet fundet sikkert at anvende hos avlshunde, drægtige hunde og diegivende hunde.
English: Spot-on-solution.
Danish: Spot-on, opløsning.
English: This veterinary medicinal product is a systemic insecticide and acaricide that provides immediate and persistent flea (Ctenocephalides felis) and tick (Ixodes ricinus) killing activity for 12 weeks.
Danish: Dette veterinærlægemiddel er et systemisk insekticid og acaricid, der har øjeblikkelig og vedvarende dræbende effekt på lopper (Ctenocephalides felis) og flåter (Ixodes ricinus) i 12 uger.
English: Safety was demonstrated in puppies aged 8-9 weeks and weighing 2.0-3.6 kg treated with overdoses of up to 5 times the maximum recommended dose on three occasions at shorter intervals than recommended (8-week intervals).
Danish: Sikkerhed er påvist hos hvalpe i alderen 8-9 uger og med en vægt på 2-3,6 kg, som blev behandlet med en overdosis på op til 5 gange den anbefalede maksimumdosis ved tre lejligheder med kortere interval end anbefalet (8 ugers interval).
English: EU/2/13/158/016 (112.5 mg, 1 pipette) EU/2/13/158/017 (112.5 mg, 2 pipettes) EU/2/13/158/020 (250 mg, 1 pipette) EU/2/13/158/021 (250 mg, 2 pipettes) EU/2/13/158/024 (500 mg, 1 pipette) EU/2/13/158/025 (500 mg, 2 pipettes) EU/2/13/158/028 (1,000 mg, 1 pipette) EU/2/13/158/029 (1,000 mg, 2 pipettes) EU/2/13/158/030 (1,400 mg, 1 pipette) EU/2/13/158/031 (1,400 mg, 2 pipettes)
Danish: EU/2/13/158/016 (112,5 mg, 1 pipette) EU/2/13/158/017 (112,5 mg, 2 pipetter) EU/2/13/158/020 (250 mg, 1 pipette) EU/2/13/158/021 (250 mg, 2 pipetter) EU/2/13/158/024 (500 mg, 1 pipette) EU/2/13/158/025 (500 mg, 2 pipetter) EU/2/13/158/028 (1.000 mg, 1 pipette) EU/2/13/158/029 (1.000 mg, 2 pipetter) EU/2/13/158/030 (1.400 mg, 1 pipette) EU/2/13/158/031 (1.400 mg, 2 pipetter)
English: The veterinary medicinal product was well tolerated in Collies with a deficient multidrug-resistanceprotein 1 (MDR1 -/-) following single oral administration at 3 times the recommended dose (168 mg/kg bodyweight).
Danish: Veterinærlægemidlet tolereredes godt hos collier, der er bærere af MDR1 gendefekt (multidrug resistance) efter en enkelt oral administration 3 gange den anbefalede dosis (168 mg/kg kropsvægt).
English: Manufacturer responsible for batch release: Intervet Productions
Danish: Fremstiller ansvarlig for batchfrigivelse Intervet Productions Rue de Lyons
English: EU/2/13/158/018 (112.5 mg, 1 pipette) EU/2/13/158/019 (112.5 mg, 2 pipettes) EU/2/13/158/022 (250 mg, 1 pipette) EU/2/13/158/023 (250 mg, 2 pipettes) EU/2/13/158/026 (500 mg, 1 pipette) EU/2/13/158/027 (500 mg, 2 pipettes)
Danish: EU/2/13/158/018 (112.5 mg, 1 pipette) EU/2/13/158/019 (112.5 mg, 2 pipetter) EU/2/13/158/022 (250 mg, 1 pipette) EU/2/13/158/023 (250 mg, 2 pipetter) EU/2/13/158/026 (500 mg, 1 pipette) EU/2/13/158/027 (500 mg, 2 pipetter)
English: Pork liver flavour Sucrose
Danish: Svineleveraroma Saccharose
English: In the absence of available data, the product should not be used on puppies less than 8 weeks old and /or dogs weighing less than 2 kg.
Danish: På grund af manglende data bør produktet ikke anvendes til hvalpe under 8 uger og/eller hunde, der vejer mindre end 2 kg.
English: This veterinary medicinal product was well tolerated in collies with a deficient multidrug-resistanceprotein 1 (MDR1 -/-) following single oral administration at 3 times the maximum recommended dose.
Danish: Dette veterinærlægemiddel tolereredes godt hos Collier, der er bærere af MDR1 gendefekt (Multidrug Resistance) efter en enkelt oral administration 3 gange den anbefalede højeste dosis.
English: Shelf life of the veterinary medicinal product as packaged for sale: Bravecto 112.5 mg spot-on solution: 2 years Bravecto 250 mg / 500 mg / 1,000 mg / 1,400 mg spot-on solution: 3 years
Danish: Bravecto 112,5 mg spot-on, opløsning: 2 år Bravecto 250 mg / 500 mg / 1.000 mg / 1.400 mg spot-on, opløsning: 3 år
English: The veterinary medicinal product was well tolerated in collies with a deficient multidrug-resistanceprotein 1 (MDR1 -/-) following single oral administration at 3 times the recommended dose.
Danish: Veterinærlægemidlet tolereredes godt hos collier, der er bærere af MDR1 gendefekt (multidrug resistance) efter en enkelt oral administration 3 gange den anbefalede dosis.
English: No adverse reactions were observed following topical administration to puppies aged 8-9 weeks and weighing 2.0-3.7 kg treated with overdoses of up to 5 times the maximum recommended dose (56 mg, 168 mg and 280 mg fluralaner/kg bodyweight) on three occasions at shorter intervals than recommended (8-week intervals).
Danish: Der blev hos hvalpe i alderen 8-9 uger og med en vægt på 2-3,7 kg ikke observeret bivirkninger efter topikal administration af op til 5 gange den højeste anbefalede dosis (56 mg, 168 mg og 280 mg fluralaner/kg kropsvægt) ved tre lejligheder med kortere interval end anbefalet (8 ugers interval).
English: In the absence of available data, this veterinary medicinal product should not be used on puppies less than 8 weeks old and /or dogs weighing less than 2 kg.
Danish: På grund af manglende data bør dette veterinærlægemiddel ikke anvendes til hvalpe under 8 uger og/eller hunde, der vejer mindre end 2 kg.
English: Mild and transient skin reactions at the application site, such as erythema and pruritus or alopecia were commonly observed in clinical trials (2.2% of treated cats).
Danish: Milde og forbigående hudreaktioner på applikationsstedet såsom erytem og pruritus eller alopeci var almindeligt observerede bivirkninger i kliniske studier (2,2 % af de behandlede katte).
English: No adverse reactions were observed following oral administration to puppies aged 8-9 weeks and weighing 2.0-3.6 kg treated with overdoses of up to 5 times the maximum recommended dose (56 mg, 168 mg and 280 mg fluralaner/kg bodyweight) on three occasions at shorter intervals than recommended (8-week intervals).
Danish: Hos hvalpe i alderen 8-9 uger og med en vægt på 2-3,6 kg blev der ikke observeret bivirkninger efter oral indgivelse af op til 5 gange den maksimalt anbefalede dosis (56 mg, 168 mg og 280 mg fluralaner/kg kropsvægt) ved tre lejligheder med kortere interval end anbefalet (8 ugers interval).
English: Safety was demonstrated in kitten aged 11-13 weeks and weighing 1.2-1.5 kg treated with overdoses of up to 5 times the maximum recommended dose on three occasions at shorter intervals than recommended (8-week intervals).
Danish: Overdosis (symptomer, nødforanstaltninger, modgift) Sikkerhed er påvist hos killinger i alderen 11-13 uger og med en vægt på 1,2-1,5 kg, som blev behandlet med en overdosis på op til 5 gange den anbefalede højeste dosis ved tre lejligheder med kortere interval end anbefalet (8 ugers interval).